SEQUANA MEDICAL NV (SEQUA.BR)
BE0974340722 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 370.5K -61.54% | 922.69K 149.04% | 712.17K -22.82% | 274.67K -61.43% | 2.403M 774.87% | 16.635M 592.26% | |
| EBITDA YoY % growth | -22.205M -29.81% | -27.783M -25.12% | -28.201M -1.50% | -18.883M 33.04% | -9.013M 52.27% | -13.545M -50.29% | |
| EBIT YoY % growth | -22.614M -29.87% | -28.094M -24.24% | -28.862M -2.73% | -20.947M 27.42% | -9.762M 53.40% | -7.416M 24.03% | |
| Operating Margin | -6,103.55% | -3,044.84% | -4,052.71% | -7,626.28% | -406.23% | -44.58% | |
| EPS YoY % growth | N/A 6.02% | N/A 3.73% | N/A 7.20% | -0.78 32.24% | -0.24 68.94% | -0.16 31.91% |
All data in EUR
| Q3 / 24 | Q4 / 24 | |
|---|---|---|
| EPS Q2Q % growth | -0.15 50.00% | -0.12 58.62% |
| Revenue Q2Q % growth | 103K -56.52% | 103K -68.60% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.901M 41.06% | -4.901M 63.55% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 53.13% | -0.15 | % | |
| Q1 2024 Q2Q % growth | 48.57% | -0.19 | % | |
| Q4 2023 Q2Q % growth | 9.38% | -0.30 | % | |
| Q3 2023 Q2Q % growth | 6.25% | -0.31 | % | |
| Q2 2023 Q2Q % growth | 52.94% | -0.33 | % | |
| Q1 2023 Q2Q % growth | -16.67% | -0.36 | % | |
| Q4 2022 Q2Q % growth | -6.67% | -0.33 | % | |
| Q3 2022 Q2Q % growth | -0.33 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2024 Q2Q % growth | 105.5K -72.54% | 103K | 2.5K | 2.43% |
| Q1 2024 Q2Q % growth | -60.00% | 103K | % | |
| Q4 2023 Q2Q % growth | 328K -28.42% | 257.5K | 70.5K | 27.38% |
| Q3 2023 Q2Q % growth | 15.00% | 236.9K | % | |
| Q2 2023 Q2Q % growth | 384.17K -17.28% | 267.8K | 116.37K | 43.45% |
| Q1 2023 Q2Q % growth | 1,566.67% | 257.5K | % | |
| Q4 2022 Q2Q % growth | 458.24K 31.68% | 206K | 252.24K | 122.45% |
| Q3 2022 Q2Q % growth | 1,233.33% | 206K | % | |
| Q2 2022 Q2Q % growth | 464.45K 1,964.22% | 15.45K | 449K | 2,906.15% |
| Q4 2021 Q2Q % growth | 348K -5.60% | 15.45K | 332.55K | 2,152.43% |
| Q2 2021 Q2Q % growth | 22.5K -96.22% | % | ||
| Q4 2020 Q2Q % growth | 368.63K -33.89% | % | ||
| Q2 2020 Q2Q % growth | 594.66K 43.98% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -7.14% | 0% | 0.44% |
| Revenue | 0% | 0% | 0% | -11.11% |